Clinical Trial

Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Propofol and rocuronium may cause pain during intravenous injection. Various pharmacological agents are used to reduce the incidence and severity of injection pain. Among the most commonly used agents for this purpose are lidocaine, various opioids, ketamine, paracetamol, and dexmedetomidine. The aim of this study was to evaluate the comparative effect of intravenous dexmedetomidine and paracetamol versus lidocaine in preventing propofol- and rocuronium-induced pain during anesthesia induction.
Trial Details
NCT Number NCT07169227
Lead Sponsor Baskent University
Conditions Propofol Injection Pain, Rocuronium Injection Pain
Enrollment 170 participants
Start Date 2025-09
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-11